For the Inventor, By the Inventor

Enter assignee name

Tucson, AZ, United States of America

Research Corporation Technologies, Inc.

USPTO Granted Patents = 366

CIPO Patents = 43

EPO Patents = 10

Trademarks = 3

Forward Citations = 7,476

Loading Chart...

Loading Chart...

408 inventors (with patents filed for the assignee):

Louis A Carpino (15 out of 26 patents)

Richard Craig (13 out of 27 patents)

Kurt R Gehlsen (12 out of 12 patents)

4. John D Buynak (11 out of 21 patents)

5. William H Pirkle (11 out of 11 patents)

6. Eric T Kool (10 out of 35 patents)

7. Shohei Koide (9 out of 25 patents)

8. David M Center (9 out of 15 patents)

9. Hardy Kornfeld (9 out of 14 patents)

10. William W Cruikshank (8 out of 17 patents)

11. Christopher J Welch (8 out of 8 patents)

12. Thomas G Chappell (7 out of 10 patents)

13. Kevin J Parker (7 out of 35 patents)

14. Arthur G Schwartz (7 out of 14 patents)

15. Robert A Magarian (7 out of 11 patents)

Core Competencies:

Pichia Pastoris

Glycan Structure

Polypeptides

Ribotoxin Molecules

Protein Glycosylation

Antibody-Like Polypeptides

Gram Negative Bacteria

Ultrasonic Imaging

Enantioselective Catalysis

Beta-Lactamase Inhibition

Magnetic Resonance Imaging

Heterologous Polypeptides

366 patents: Sort by Forward Citations

1. 12359211 - Pichia pastoris strains for producing predominantly homogeneous glycan structure (2025-07-15),

2. 11866715 - strains for producing predominantly homogeneous glycan structure (2024-01-09),

3. 11542321 - Engineered stable CH2 polypeptides (2023-01-03),

4. 11220692 - strains for producing predominantly homogeneous glycan structure (2022-01-11),

5. 10829558 - Small antibody-like polypeptides that bind to EPHA2 receptor (2020-11-10),

6. 10612033 - strains for producing predominantly homogeneous glycan structure (2020-04-07),

7. 10370440 - Reconstituted polypeptides (2019-08-06),

8. 10329572 - Pichia pastoris strains for producing predominantly homogeneous glycan structure (2019-06-25),

9. 10113164 - [object Object] (2018-10-30),

10. 9976131 - Ribotoxin molecules derived from sarcin and other related fungal ribotoxins (2018-05-22),

11. 9803210 - Fusion proteins comprising immunoglobulin constant domain-derived scaffolds (2017-10-31),

12. 9617550 - [object Object] (2017-04-11),

13. 9603911 - Ribotoxin molecules derived from sarcin and other related fungal ribotoxins (2017-03-28),

14. 9458454 - Viable gram negative bacteria with reduced proteolytic activity lacking outer membrane agonists of TLR4/MD-2 (2016-10-04),

15. 9359628 - Protein glycosylation modification in methylotrophic yeast (2016-06-07),

Research Corporation Technologies, Inc. is a technology management and investment company that provides support and funding for early-stage technology development. With a focus on commercializing innovative technologies, RCT works with inventors, universities, and research institutions to create successful ventures and bring cutting-edge products to market. Through strategic partnerships and licensing agreements, RCT aims to maximize the value of intellectual property and drive technological advancements across various industries.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

366 Patents

#3 in Tucson, AZ

#13 in Arizona

#1,203 in US

#2,433 in the World

Tucson, AZ, United States of America

Research Corporation Technologies, Inc.

Forward Citations = 7,476

408 inventors:

Louis A Carpino (15 out of 26 patents)

Richard Craig (13 out of 27 patents)

Kurt R Gehlsen (12 out of 12 patents)

4. John D Buynak (11 out of 21 patents)

5. William H Pirkle (11 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…